Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation

Retinal stem cells (RSCs) are promising in cell replacement strategies for retinal diseases. RSCs can migrate, differentiate, and integrate into retina. However, RSCs transplantation needs an adequate support; chitosan membrane (ChM) could be one, which can carry RSCs with high feasibility to support their integration into retina. RSCs were isolated, evaluated for phenotype, and subsequently grown on sterilized ChM and polystyrene surface for 8 hours, 1, 4, and 11 days for analysing cell adhesion, proliferation, viability, and phenotype. Isolated RSCs expressed GFAP, PKC, isolectin, recoverin, RPE65, PAX-6, cytokeratin 8/18, and nestin proteins. They adhered (28 ± 16%, 8 hours) and proliferated (40 ± 20 cells/field, day 1 and 244 ± 100 cells/field, day 4) significantly low on ChM. However, they maintained similar viability (>95%) and phenotype (cytokeratin 8/18, PAX6, and nestin proteins expression, day 11) on both surfaces (ChM and polystyrene). RSCs did not express alpha-SMA protein on both surfaces. RSCs express proteins belonging to epithelial, glial, and neural cells, confirming that they need further stimulus to reach a final destination of differentiation that could be provided in in vivo condition. ChM does not alternate RSCs behaviour and therefore can be used as a cell carrier so that slow proliferating RSCs can migrate and integrate into retina

A STUDY OF RECOVERY FROM GENERAL ANAESTHESIA AFTER PREOPERATIVE ADMINISTRATION OF ANTIMICROBIAL

ABSTRACT Antimicrobials are used prophylactily in any major surgery to cover perioperative wound infection and other infectious complication ,that may have interaction with muscle relaxant used for general anesthesia and the aim of our study is drug interaction and behavioural response of newly introduced antibiotics used with rocuronium. Gentamicin shortened onset and duration of block after intubating dose of rocuronium and also prolonged duration of extubation after last dose of rocuronium where as meropenem and ceftriaxone did not alter onset, duration and recovery characterstics of rocuronium. . From our study we can conclude that meropenem and ceftriaxone but not gentamicin, can be used safely during general anesthesia. The near ideal muscle relaxant must span the range of short, intermediate and long acting duration (as required by surgical procedure),have rapid onset, be highly metabolized, have no cumulative or cardiovascular effect, to be independent of kidney for elimination, and be easily antagonized. The most commonly used clinical agentsatracurium, doxacurium, vecuronium, pancuronium and pipecuronium-demonstrate some, but not all, of these properties. KEYWORDS : Rocuronium bromide is a relatively new nondepolarizing muscle relaxant. It is the first of these agents to have an onset time possibly as brief as that of suxamethonium without adverse side effect. Rocuronium bromide is mono-quaternary, aminosteroidal, nondepolarizing neuromuscular blocking agent with a rapid onset of actio

Progress in wound-healing products based on natural compounds, stem cells, and microRNA-based biopolymers in the european, USA, and asian markets: opportunities, barriers, and regulatory Issues

Wounds are breaks in the continuity of the skin and underlying tissues, resulting from external causes such as cuts, blows, impacts, or surgical interventions. Countless individuals suffer minor to severe injuries, with unfortunate cases even leading to death. In today’s scenario, several commercial products are available to facilitate the healing process of wounds, although chronic wounds still present more challenges than acute wounds. Nevertheless, the huge demand for wound-care products within the healthcare sector has given rise to a rapidly growing market, fostering continuous research and development endeavors for innovative wound-healing solutions. Today, there are many commercially available products including those based on natural biopolymers, stem cells, and microRNAs that promote healing from wounds. This article explores the recent breakthroughs in wound-healing products that harness the potential of natural biopolymers, stem cells, and microRNAs. A comprehensive exploration is undertaken, covering not only commercially available products but also those still in the research phase. Additionally, we provide a thorough examination of the opportunities, obstacles, and regulatory considerations influencing the potential commercialization of wound-healing products across the diverse markets of Europe, America, and Asia

Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials

Producción CientíficaRetinal and optic nerve diseases are degenerative ocular pathologies which lead to irreversible visual loss. Since the advanced therapies availability, cell-based therapies offer a new all-encompassing approach. Advances in the knowledge of neuroprotection, immunomodulation and regenerative properties of mesenchymal stem cells (MSCs) have been obtained by several preclinical studies of various neurodegenerative diseases. It has provided the opportunity to perform the translation of this knowledge to prospective treatment approaches for clinical practice. Since 2008, several first steps projecting new treatment approaches, have been taken regarding the use of cell therapy in patients with neurodegenerative pathologies of optic nerve and retina. Most of the clinical trials using MSCs are in Ⅰ/Ⅱ phase, recruiting patients or ongoing, and they have as main objective the safety assessment of MSCs using various routes of administration. However, it is important to recognize that, there is still a long way to go to reach clinical trials phase Ⅲ-Ⅳ. Hence, it is necessary to continue preclinical and clinical studies to improve this new therapeutic tool. This paper reviews the latest progress of MSCs in human clinical trials for retinal and optic nerve diseasesJunta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA066U13

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates of overweight and wasting prevalence among children under 5 years of age in 105 low- and middle-income countries (LMICs) from 2000 to 2017 and aggregate these to policy-relevant administrative units. Wasting decreased overall across LMICs between 2000 and 2017, from 8.4% (62.3 (55.1–70.8) million) to 6.4% (58.3 (47.6–70.7) million), but is predicted to remain above the World Health Organization’s Global Nutrition Target of <5% in over half of LMICs by 2025. Prevalence of overweight increased from 5.2% (30 (22.8–38.5) million) in 2000 to 6.0% (55.5 (44.8–67.9) million) children aged under 5 years in 2017. Areas most affected by double burden of malnutrition were located in Indonesia, Thailand, southeastern China, Botswana, Cameroon and central Nigeria. Our estimates provide a new perspective to researchers, policy makers and public health agencies in their efforts to address this global childhood syndemic

Polyethylene/Polyhydroxyalkanoates-based Biocomposites and Bionanocomposites

The development of advanced polymer composite materials having superior mechanical properties has opened up new horizons in the field of science and engineering. Polyethylene (PE) is considered one of the most widely used thermoplastics in the world due to its excellent properties which have excellent chemical inertness, low coefficient of friction, toughness, near-zero moisture absorption, ease of processing and electrical properties. Polyhydroxyalkanoates (PHAs) are garnering increasing attention in the biodegradable polymer market because of their promising properties such as high biodegradability in different environments. This chapter covers polyethylene/polyhydroxyalkanoates-based biocomposites and bionanocomposites. It summarizes many of the recent research accomplishments in the area of PE/PHAs-based biocomposites and bionanocomposites such as state-of-the-art regarding different methods of their preparation. Also discussed are different characterization techniques and use of PE/PHAs-based biocomposites and bionanocomposites in biomedical, packaging, structural, military, coating, fire retardant, aerospace and optical applications, along with recycling and lifetime studies

Not Available

Not AvailableNot AvailableNot Availabl

Not Available

Not AvailableDairy sector plays a catalytic role in Indian agricultural economy by contributing 68 per cent of total livestock output and 18 per cent of total agricultural output. Further, milk and milk products (MMPs) are the second largest constituents of Indian food budget after cereals. However, there exist wide inter-regional variability in its production and consumption. The paper diagnoses inter-regional variations in production performance and highlights the accessibility and affordability issues in consumption ofMMPs. The changes in price and income have significant influence in the consumption ofMMPs as revealed by high estimated price and income elasticities. The demand and production projections revealed that domestic demand of MMPs will outstrip the production in future. This necessitates acceleration in milk production through technological and policy breakthrough to balance demand and supply.Not Availabl